IDEXX Laboratories (IDXX)
(Real Time Quote from BATS)
$484.40 USD
-9.86 (-2.00%)
Updated Apr 25, 2024 01:10 PM ET
2-Buy of 5 2
C Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/1/24 |
---|---|
Current Quarter | 2.68 |
EPS Last Quarter | 2.32 |
Last EPS Surprise | 9.43% |
ABR | 1.77 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 11.15 |
Next Year | 12.77 |
EPS (TTM) | 10.07 |
P/E (F1) | 44.33 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 966.40M | 1.03B | 3.99B | 4.41B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 968.30M | 1.04B | 4.00B | 4.46B |
Low Estimate | 965.26M | 1.02B | 3.98B | 4.37B |
Year ago Sales | 900.20M | 943.63M | 3.66B | 3.99B |
Year over Year Growth Est. | 7.35% | 8.85% | 9.04% | 10.37% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.68 | 2.99 | 11.15 | 12.77 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | 2.68 | 2.98 | 11.17 | 12.79 |
High Estimate | 2.75 | 3.03 | 11.20 | 12.92 |
Low Estimate | 2.60 | 2.98 | 11.10 | 12.60 |
Year ago EPS | 2.55 | 2.67 | 10.06 | 11.15 |
Year over Year Growth Est. | 5.10% | 11.99% | 10.83% | 14.57% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.68 | 2.99 | 11.15 | 12.77 |
7 Days Ago | 2.68 | 2.99 | 11.15 | 12.77 |
30 Days Ago | 2.68 | 2.99 | 11.15 | 12.77 |
60 Days Ago | 2.69 | 2.97 | 11.13 | 12.77 |
90 Days Ago | 2.71 | 2.95 | 10.99 | 12.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.68 | 2.99 | 11.15 | 12.79 |
Zacks Consensus Estimate | 2.68 | 2.99 | 11.15 | 12.77 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.14% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.32 | 2.53 | 2.67 | 2.55 | NA |
Estimate | 2.12 | 2.37 | 2.43 | 2.38 | NA |
Difference | 0.20 | 0.16 | 0.24 | 0.17 | 0.19 |
Surprise | 9.43% | 6.75% | 9.88% | 7.14% | 8.30% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more